Original research: Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study (29 September, 2023)
Serena Ruggieri, Luca Prosperini, Sarmad Al-Araji, Pietro Osvaldo Annovazzi, Alvino Bisecco, Olga Ciccarelli, Nicola De Stefano, Massimo Filippi, Vinzenz Fleischer, Nikos Evangelou, Christian Enzinger, Antonio Gallo, Afagh Garjani, Sergiu Groppa, Shalom Haggiag, Michael Khalil, Matteo Lucchini, Massimiliano Mirabella, Xavier Montalban, Carlo Pozzilli, Paolo Preziosa, Jordi Río, Maria A Rocca, Alex Rovira, Maria L Stromillo, Mauro Zaffaroni, Carla Tortorella, Claudio Gasperini
Editorial commentary